Advanced search
Publication Cover
Climacteric Volume 4, 2001 - Issue 1
Submit an article Journal homepage
51
Views
11
CrossRef citations to date
0
Altmetric
(RG) Obstetrics and Gynaecology

Perimenopausal women in estrogen vasomotor trials: contribution to placebo effect and efficacy outcome

J. A. Simon Department of Obstetrics and Gynecology, George Washington University School of Medicine, Washington, DC.
,
R. E. Stevens Duramed Pharmaceuticals, Inc., Cincinnati, OH, USA.
,
S. A. Ayres Duramed Pharmaceuticals, Inc., Cincinnati, OH, USA.
&
K. V. Phelps Duramed Pharmaceuticals, Inc., Cincinnati, OH, USA.
Pages 19-27 | Published online: 03 Jul 2009

References

  • Hammond CB. Menopause and hormone replacement therapy: an overview. Obstet Gynecol 1996;87:2S–15S
  • Kronenberg F. Hot flashes: epidemiology and physiology. Ann NY Acad Sci 1990;592:52–86
  • Food and Drug Administration. Guidance for clinical evaluation of combination estrogen/ proges tin-containingdrug products used for hormone replacement therapy of postmeno-pausal women. Communication from the Division of Metabolism and Endocrine Drug Products (DMEDP), prepared 3/7/95, approved 3/20/95. Rockville, MD: FDA, 1995
  • Burger HG, Dudley EC, Hopper JL, et al. Prospectively measured levels of serum follicle-stimulating hormone, estradiol, and the dimeric inhibins during the menopausal transition in a population-based cohort of women. J Clin Endo-crinol Metab 1999;84:4025–30
  • Dennerstein L, Dudley EC, Hopper JL, Guthrie JR, Burger HG. A prospective population-based study of menopausal symptoms. Obstet Gynecol 2000;96:351–8
  • Coope J, Thomson JM, Potter L. Effects of 'natural oestrogen' replacement therapy on menopausal symptoms and blood clotting. Br Med J 1975;4:139–43
  • Speroff L, Whitcomb RW, Kempfert NJ, Boyd RA, Paulissen JB, Rowan J. Efficacy and local tolerance of a low-dose, 7-day matrix estradiol transdermal system in the treatment of meno-pausal vasomotor symptoms. Obstet Gynecol 1996;88:587–92
  • Potter L, Thomson JM, Coope J. A double-blind cross-over study of piperazine oestrone sulphate and placebo with coagulation studies. Br J Obstet Gynaecol 1980;87:718–25
  • Gordon SF, Thompson KA, Ruoff GE, Imig JR, Lane PJ, Schwenker C. Efficacy and safety of a seven-day, transdermal estradiol drug-delivery system: comparison with conjugated estrogens and placebo. Int J Fertil 1995;40:126–34
  • Kendle International Inc., Clinical Development Organization, Cincinnati, OH
  • SAS Institute. SASISTAT® User's Guide, Version 6, 4th ed. Cary, NC: SAS Institute, 1989;2: 1027–69
  • Adams W. Summary Basis for Approval for abbreviated new drug application 81–295 (Estrace). Rockville, MD: Fl 14 September 1992:1–4
  • Erlik Y, Meldrum DR, Judd HL. Estrogen levels in postmenopausal women with hot flashes. Obstet Gynecol 1982;59:403–7
  • Stone SC, Mickal A, Rye PH. Postmenopausal symptomatology, maturation index, and plasma estrogen levels. Obstet Gynecol 1975;45:625–7
  • Steingold K, Laufer L, Chetkowski RJ, et al. Treatment of hot flashes with transdermal estra-diol administration. J Clin Endocrinol Metab 1985;61:627–32
  • Albrecht BH, Schiff I, Tulchinsky D, Ryan KJ. Objective evidence that placebo and medroxy-progesterone acetate therapy diminish meno-pausal vasomotor flushes. Am J Obstet Gynecol 1981;139:631–5
  • Dobrilla G, Scarpignato C. Placebo and placebo effect: their impact on the evaluation of drug response in patients. Dig Dis 1994;12:368–77
  • Haas S, Walsh B, Evans S, Krache M, Ravnikar V, Schiff I. The effect of transdermal estradiol on hormone and metabolic dynamics over a six-week period. Obstet Gynecol 1988;71:671–6
  • Schiff I. Menopause. In Kistner RW, ed. Gynecology: Principles and Practice. Chicago, IL: Year Book Medical Publishers, 1986:565–82
  • MacLennan A, Lester S, Moore V. Oral oestro-gen replacement therapy versus placebo for hot flushes (Cochrane Review). The Cochrane Library, 1. Oxford: Update Software, 2001
  • Santoro NF, Col NF, Eckman MH, et al. Hormone replacement therapy — where are we going? J Clin Endocrinol Metab 1999;84: 1798–812
  • Roddick JW. Use of estrogens in the climacteric and postmenopausal years. Clin Obstet Gynecol 1977;20:903–11
  • Prior JC. Perimenopause: the complex endo-crinology of the menopausal transition. Endocr Rev 1998;19:397–428
  • Aedo AR, LeDonne M, Landgren BM, Diczfalusy E. Effect of orally administered oestrogens on gonadotrophin levels in postmenopausal women. Maturitas 1989;11:147–57
  • Strickler RC, Borth R, Cecutti A, et al. The role of oestrogen replacement in the climacteric syndrome. Psychol Med 1977;7:631–9
  • Ottenbacher K. Statistical power and research in occupational therapy. Occup Ther J Res 1982; 2:13
  • Good WR, John VA, Ramirez M, Higgins JE. Double-masked, multicenter study of an estradiol matrix transdermal delivery system (Alora) versus placebo in postmenopausal women experiencing menopausal symptoms. Clin Ther 1996;18:1093–105

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.